Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	687.84	504.86	64.08
Graham Fair Price	-34.45	2.15	3.29
PEG	1343.89	1.20	-0.08
Price/Book	31.00	2.94	2.25
Price/Cash Flow	inf	0.00	36.24
Prices/Earnings	-201.64	-68.55	-22.72
Price/Sales	139.35	5.43	2.27
Price/FCF	inf	0.00	36.24
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-61.02	0.02	0.06
Operating Margin	42.30	-0.01	-0.02
ROA	inf	0.00	< 0.005
ROE	-0.02	-0.01	56.57
ROIC	-0.02	-0.01	54.01
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-1.00	0.00	-100.00
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-1.68	0.69	-59.23
EPS QOQ	-2.74	0.57	-79.11
FCF QOQ	0.00	-1.00	-100.00
Revenue QOQ	1.08	-0.46	-57.72
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.22	0.00	inf
Days Sales Outstanding (DSO)	93.76	0.00	inf
Inventory Turnover	410.84	0.00	inf
Debt/Capitalization	0.08	0.00	inf
Quick Ratio	1.40	0.00	inf
Naive Interpretation	member

04 - Leverage & Liquidity · Not Interpreted

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	4.40	4.38	-0.53
Cash	2.40	7.81	224.65
Capex	-0.08	0.00	inf
Free Cash Flow	0.27	0.00	inf
Revenue	4.37	2.38	-45.56
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.42	0.00	inf
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-14.41	-152.83	-960.28
Naive Interpretation	Member

06 - Financial Health · Bad

Rating